Aristo Bio-Tech and Lifescience Limited informed the Exchange about the outcome of their board meeting, including the approval of Directors Report, re-appointment of Managing Director and Independent Director, convening of Annual General Meeting, fixed record date for final dividend, appointment of Scrutinizer and Remote E-Voting Agency, and approved alteration of Articles of Association.